Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients - Full Text View

Purpose

Patients who need major head & neck surgery are at risk of post operative wound infection. In spite of role of antibiotics in prophylaxis of clean contaminated head and neck surgery has been well documented, controversy exists in the optimal antibiotic regimen

Condition	Intervention	Phase
Laryngeal Cancer	Drug: cefazolin	Phase III

MedlinePlus related topics:

Antibiotics Cancer

ChemIDplus related topics:

Cefazolin Cefazolin sodium

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study

Official Title:	Double Blind Randomised Study of 2 Days and 5 Days Cefazolin Prophylactic Method in Laryngeal Oncologic Surgery

Further study details as provided by Tehran University of Medical Sciences:

Primary Outcome Measures:

wound infection [ Time Frame: prospective ]

Secondary Outcome Measures:

drug complication [ Time Frame: 3 week after surgery ]

Enrollment:	90
Study Start Date:	June 2004
Study Completion Date:	March 2006

Detailed Description:

Patients undergoing laryngeal oncologic surgery are at relatively high risk of developing complication.

Efficacy of cefazolin as a prophylactic antibiotic in head and neck surgery was reviewed in many researches [6] but considering the costs and morbidities of prolonged antibiotic regimen we have presented a prospective and randomized study in 90 patients comparing the efficacy of 2 day over 5 day protocols.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:e.

Patients eligible to be included in this trial were those who histologically confirmed squamous cell carcinoma of larynx and hypopharynx and they were candidate of total or partial laryngectomy with or without neck dissection and with negative history of neck or laryngeal radiation were included in this study.

Exclusion Criteria:

Patients having recurrences or another primary tumor, and those who underwent reconstruction with a flap were excluded from the study, because they had been submitted to prolonged antibiotic administration. Also cases with Diabet mellitus and Immune suppression or tumor types other than squamous cell carcinoma were excluded from the study.
In addition, the following exclusion criteria were taken into account: pregnancy, hypersensitivity to penicillins or cephalosporins, patients who received a systemic antibiotic drug within one week prior to the planned procedure, those who had clinical or laboratory evidence of a preexisting infection or had serious systemic renal disease.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00467948

Locations


Iran, Islamic Republic of
	Imam khomaini hospital
	tehran, Iran, Islamic Republic of, 19799

Sponsors and Collaborators

Tehran University of Medical Sciences

Investigators


Study Chair:	taghi khorsandi, professor	tehran university of medical science

More Information

Study ID Numbers:	BS_200306
First Received:	April 29, 2007
Last Updated:	April 30, 2007
ClinicalTrials.gov Identifier:	NCT00467948
Health Authority:	Iran: Ethics Committee

Keywords provided by Tehran University of Medical Sciences:

clean contaminated, laryngectomy, wound infection

Study placed in the following topic categories:

Cefazolin

Otorhinolaryngologic Diseases

Otorhinolaryngologic Neoplasms

Respiratory Tract Diseases

Head and Neck Neoplasms

Laryngeal carcinoma

Laryngeal Neoplasms

Laryngeal Diseases

Wound Infection

Additional relevant MeSH terms:

Anti-Infective Agents

Anti-Bacterial Agents

Respiratory Tract Neoplasms

Neoplasms

Neoplasms by Site

Therapeutic Uses

Pharmacologic Actions

ClinicalTrials.gov processed this record on September 05, 2008

Sponsored by:	Tehran University of Medical Sciences
Information provided by:	Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:	NCT00467948